These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 31843450)
1. A Molecular Revolution in the Treatment of Hemophilia. Butterfield JSS; Hege KM; Herzog RW; Kaczmarek R Mol Ther; 2020 Apr; 28(4):997-1015. PubMed ID: 31843450 [TBL] [Abstract][Full Text] [Related]
2. Emerging genetic and pharmacologic therapies for controlling hemostasis: beyond recombinant clotting factors. Monahan PE Hematology Am Soc Hematol Educ Program; 2015; 2015():33-40. PubMed ID: 26637698 [TBL] [Abstract][Full Text] [Related]
3. The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges. Trinchero A; Sholzberg M; Matino D Hamostaseologie; 2020 Aug; 40(3):311-321. PubMed ID: 32726826 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in developing specific therapies for haemophilia. Ling G; Nathwani AC; Tuddenham EGD Br J Haematol; 2018 Apr; 181(2):161-172. PubMed ID: 29359795 [TBL] [Abstract][Full Text] [Related]
5. New therapies for hemophilia. Weyand AC; Pipe SW Blood; 2019 Jan; 133(5):389-398. PubMed ID: 30559264 [TBL] [Abstract][Full Text] [Related]
8. The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing. Mancuso ME; Mahlangu JN; Pipe SW Lancet; 2021 Feb; 397(10274):630-640. PubMed ID: 33460559 [TBL] [Abstract][Full Text] [Related]
9. Advances in gene therapy for hemophilia: basis, current status, and future perspectives. Ohmori T Int J Hematol; 2020 Jan; 111(1):31-41. PubMed ID: 30083852 [TBL] [Abstract][Full Text] [Related]
10. [Trends in novel treatments for hemophilia]. Shima M Rinsho Ketsueki; 2016; 57(10):2259-2266. PubMed ID: 27795538 [TBL] [Abstract][Full Text] [Related]
12. Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues. Leebeek FWG; Miesbach W Blood; 2021 Sep; 138(11):923-931. PubMed ID: 34232980 [TBL] [Abstract][Full Text] [Related]
13. New therapies using nonfactor products for patients with hemophilia and inhibitors. Nogami K; Shima M Blood; 2019 Jan; 133(5):399-406. PubMed ID: 30559263 [TBL] [Abstract][Full Text] [Related]
14. Current and future prospects for hemophilia gene therapy. Ward P; Walsh CE Expert Rev Hematol; 2016 Jul; 9(7):649-59. PubMed ID: 27153210 [TBL] [Abstract][Full Text] [Related]
15. Gene Therapy for Hemophilia: Progress to Date. Chapin JC; Monahan PE BioDrugs; 2018 Feb; 32(1):9-25. PubMed ID: 29127625 [TBL] [Abstract][Full Text] [Related]
16. 2017 Clinical trials update: Innovations in hemophilia therapy. Hartmann J; Croteau SE Am J Hematol; 2016 Dec; 91(12):1252-1260. PubMed ID: 27563744 [TBL] [Abstract][Full Text] [Related]
17. Adeno-Associated Virus Gene Therapy for Hemophilia. Samelson-Jones BJ; George LA Annu Rev Med; 2023 Jan; 74():231-247. PubMed ID: 36103998 [TBL] [Abstract][Full Text] [Related]
20. [Gene therapy of haemophilia - has the cure come within reach?]. Kaczmarek R Postepy Biochem; 2018 Dec; 64(4):318-322. PubMed ID: 30656916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]